Bausch + Lomb: Undervalued Canadian Stock
This is a news story, published by Yahoo Finance, that relates primarily to NYSE news.
stocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
other undervalued Canadian stocks. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Canadian Stocks news, cheap Canadian stocks news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Undervalued Canadian StocksInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Business
Business & Economics
Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts?
83% Informative
Bausch + Lomb Corporation ( NYSE :BLCO) is an eye health company that operates in three segments: Vision Care, Pharmaceutical , and Surgical . It sells its products and services through direct sales forces and independent distributors.
During Q4 2024 , the Vision. Care segment achieved a revenue of $723 million , which marked an 11% increase year-over-year growth.
The Vision Care segment delivered $2.7 billion in revenue, which showed 10% growth on an annual basis.
Bausch + Lomb Corp. ( NYSE :BLCO) is focused on sustained growth within its Vision Care segment through continuous innovation.
Overall, BLCO ranks 6th on our list of the most undervalued Canadian stocks to buy according to Wall Street analysts.
There is an AI stock that went up since the beginning of 2025 , while popular AI stocks lost around 25% ..
VR Score
87
Informative language
88
Neutral language
35
Article tone
formal
Language
English
Language complexity
47
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
6
Source diversity
1
Affiliate links
no affiliate links
Small business owner?